D.A. Davidson & Co’s BioLife Solutions BLFS Stock Holding History

D.A. Davidson & Co’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$959K	Buy	33,952 +635	+2%	+$14.8K	0.01%	976
2026 Q1	$636K	Sell	33,317 -4,239	-11%	-$93.7K	﹤0.01%	1076
2025 Q4	$908K	Sell	37,556 -450	-1%	-$11.8K	0.01%	921
2025 Q3	$970K	Buy	38,006 +1,466	+4%	+$34.8K	0.01%	878
2025 Q2	$787K	Sell	36,540 -3,985	-10%	-$89.8K	0.01%	888
2025 Q1	$926K	Sell	40,525 -654	-2%	-$17.2K	0.01%	791
2024 Q4	$1.07M	Buy	41,179 +519	+1%	+$12.9K	0.01%	740
2024 Q3	$1.02M	Buy	+40,660	New	+$960K	0.01%	763
2023 Q4	–	Sell	-25,000	Closed	-$345K	–	1367
2023 Q3	$345K	Hold	25,000	–	–	﹤0.01%	1039
2023 Q2	$553K	Hold	25,000	–	–	0.01%	896
2023 Q1	$544K	Hold	25,000	–	–	0.01%	864
2022 Q4	$455K	Hold	25,000	–	–	0.01%	875
2022 Q3	$569K	Sell	25,000 -5,000	-17%	-$107K	0.01%	773
2022 Q2	$414K	Buy	30,000 +10,000	+50%	+$147K	0.01%	887
2022 Q1	$455K	Buy	20,000 +10,150	+103%	+$267K	0.01%	904
2021 Q4	$367K	Buy	+9,850	New	+$423K	﹤0.01%	987

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.A. Davidson & Co's BLFS Position: Q2 2026 in Review

D.A. Davidson & Co increased its BioLife Solutions (BLFS) stake by 1.9% in Q2 2026, buying an estimated $14.8K and bringing the position to 33,952 shares worth $959K. The position accounts for 0.01% of the portfolio, ranked #976.

D.A. Davidson & Co first reported a position in BLFS in Q4 2021 and has held it in 16 quarters since. The position peaked at $1.07M in Q4 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

D.A. Davidson & Co held 33,952 shares of BioLife Solutions worth $959K as of Q2 2026.
D.A. Davidson & Co bought 635 BioLife Solutions shares in Q2 2026, an estimated $14.8K.
BioLife Solutions made up 0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #976 holding.
D.A. Davidson & Co first reported a position in BioLife Solutions in Q4 2021 and has held it in 16 quarters since.
D.A. Davidson & Co's BioLife Solutions position peaked at $1.07M in Q4 2024.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.